Publications by authors named "Lara Davis"

Claim this Profile
P
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.
Michelle Choe, Danielle Kirkey, Isabel Lira, Grace Hawkins, Melia Blankenfeld, Lara E Davis

Cancer Res Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib in Sequential Combination with Doxorubicin in Anthracycline-Naïve Advanced Soft-Tissue Sarcomas: Results of a Dose-Finding Phase Ib Study.
Lara E Davis, Limin Zhu, Emile Latour, Nathan McMahon, Go Nishikawa, Jessica L Davis

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining physical therapy and anatomy education in a high school anatomy outreach program in central Arkansas.
Lara Davis, Ciana Diaz, Kyler Hulsey, Kaylee Miller, Jaqueline Mondragon

Anat Sci Educ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study.
Lara Davis, Limin Zhu, Skye C Mayo, Emile Latour, Byung Park, Jessica L Davis

Res Sq· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers, Noah Federman, Najat Daw, Peter M Anderson, Lara E Davis

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
promising immunotherapeutic intervention for diseases.
Kirsten Stefan, Ryan Gordon, Annah Rolig, Alexander Honkala, Dhanir Tailor, Lara E Davis

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.
Yvonne M Mowery, Karla V Ballman, Angela M Hong, Scott M Schuetze, Andrew J Wagner, Lara E Davis

Lancet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib.
Hans Gelderblom, Albiruni A Razak, Matthew H Taylor, Todd M Bauer, Breelyn Wilky, Lara E Davis

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide variants in nuclear pore complex disassembly pathway associated with poor survival in osteosarcoma.
James E Jacobs, Lara Davis, Shannon McWeeney

Front Genet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group.
Susan L Whiteway, Aaron R Weiss, Safia K Ahmed, Wendy A Allen-Rhoades, Viswatej Avutu, Lara E Davis, Elizabeth J Davis

J Adolesc Young Adult Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?
Caleb Kim, Lara E Davis, Catherine M Albert, Brian Samuels, Jesse L Roberts

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraosseous Spindle Cell Rhabdomyosarcoma with :: Fusion - Case Report with Substantial Clinical Follow-up and Review of the Literature.
Benjamin F Smith, Yee-Cheen Doung, Brooke Beckett, Christopher L Corless, Lara E Davis, Jessica L Davis

Cancer Invest· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Mrinal Gounder, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T van der Graaf, Lara E Davis

N Engl J Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, Suzanne George, Mark Agulnik, Lara E Davis

Cancer Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma.
Bingbing X Li, Larry L David, Lara E Davis, Xiangshu Xiao

J Biol Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.
Devon Miller, John A Livingston, Yeonhee Park, Kristi Posey, Sonia Godbole, Lara E Davis

Cancer Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.
Viswatej Avutu, Aaron R Weiss, Damon R Reed, Safia K Ahmed, Wendy A Allen-Rhoades, Lara E Davis

J Adolesc Young Adult Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Functional impact and targetability of , , and mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.
Florence Choo, Igor Odintsov, Kevin Nusser, Katelyn Nicholson, Lara Davis, Jessica L Davis

Cold Spring Harb Mol Case Stud· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional impact and targetability of , , and mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.
Florence Choo, Igor Odintsov, Kevin Nusser, Katelyn S Nicholson, Lara Davis, Jessica L Davis

Cold Spring Harb Mol Case Stud· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages.
Bryan D Smith, Michael D Kaufman, Scott C Wise, Yu Mi Ahn, Timothy M Caldwell, Lara E Davis

Mol Cancer Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors.
Florence Choo, Dinesh Rakheja, Lara E Davis, Monika Davare, Jason Y Park, Jessica L Davis

Genes Chromosomes Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Aortic Angiosarcoma: A Review of Two Cases Highlighting Unique Imaging and Clinical Characteristics.
Case H Keltner, Ana Paula Santos Lima, Malinda West, Kenneth R Gundle, Cristina Fuss, Lara E Davis

Radiol Cardiothorac Imaging· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Richard F Riedel, Karla V Ballman, Yao Lu, Steven Attia, Elizabeth T Loggers, Lara E Davis

Oncologist· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Mrinal Gounder, Patrick Schöffski, Robin L Jones, Mark Agulnik, Gregory M Cote, Lara E Davis

Lancet Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
Eric Lu, Christopher W Ryan, Solange Bassale, Jeong Youn Lim, Lara E Davis

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis